*7.1.1.7 Medtech Innovation Briefings*

The UK's National Institution for Health and Care Excellence (NICE)), was commissioned by the UK government and advises and supports National Health Service and social care commissioners and have made a review of IQoro and its claims and effectiveness. They have issued a Medtech Innovation Briefing [47] that recognized "*IQoro is an innovative treatment, with no similar technologies currently recommended, and that the intended place in therapy would be in addition to standard speech and language therapy in people with stroke-related dysphagia*".


#### **Table 3.**

*Improved outcomes in swallowing and facial abilities.*
